Officiële publicaties ABIONYX Pharma

Aandelen

Beurs gesloten - Euronext Paris Andere beurzen 17:35:22 10-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,04 ^EUR	+1,96%		-2,80%	-19,25%

11/03	ABIONYX Pharma SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
15/02	ABIONYX Pharma SA bevestigt de klinische resultaten van de Fase 3-studie Aegis-Ii die de doeltreffendheid en veiligheid evalueert van CSL Behring's menselijk plasma-afgeleide apoA-I, CSL112.	CI

Monthly statement on voting rights	30-04-23	CO
Universal registration document	28-04-23	CO
Monthly statement on voting rights	31-03-23	CO
Monthly statement on voting rights	31-03-23	CO
Annual results	29-03-23	CO
Annual results	29-03-23	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	02-03-23	CO
Monthly statement on voting rights	28-02-23	CO
Monthly statement on voting rights	28-02-23	CO
4th quarter turnover	28-02-23	CO
4th quarter turnover	28-02-23	CO
Threshold crossings	03-02-23	CO
Monthly statement on voting rights	31-01-23	CO
Monthly statement on voting rights	31-01-23	CO
Monthly statement on voting rights	31-12-22	CO
Monthly statement on voting rights	31-12-22	CO
Monthly statement on voting rights	30-11-22	CO
Monthly statement on voting rights	30-11-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	21-11-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	21-11-22	CO
Threshold crossings	21-11-22	CO
3rd quarter turnover	17-11-22	CO
3rd quarter turnover	17-11-22	CO
Monthly statement on voting rights	31-10-22	CO
Monthly statement on voting rights	31-10-22	CO